GuiZhou SanLi Pharmaceutical Co.,Ltd (603439.SS)
CNY 13.79
(0.07%)
CNY 13.79
(0.07%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.92 Billion CNY | 60.76% |
| 2022 | 1.81 Billion CNY | 29.3% |
| 2021 | 1.4 Billion CNY | 11.61% |
| 2020 | 1.25 Billion CNY | 72.25% |
| 2019 | 730.8 Million CNY | 26.72% |
| 2018 | 576.7 Million CNY | 1.99% |
| 2017 | 565.42 Million CNY | 9.15% |
| 2016 | 518.02 Million CNY | 71.15% |
| 2015 | 302.66 Million CNY | 21.76% |
| 2014 | 248.58 Million CNY | 24.53% |
| 2013 | 199.61 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 3.05 Billion CNY | 2.03% |
| 2024 Q2 | 2.99 Billion CNY | 1.73% |
| 2024 Q1 | 2.94 Billion CNY | 0.9% |
| 2023 Q3 | 1.98 Billion CNY | 4.13% |
| 2023 Q2 | 1.9 Billion CNY | 1.06% |
| 2023 Q1 | 1.88 Billion CNY | 4.01% |
| 2023 FY | 2.92 Billion CNY | 60.76% |
| 2023 Q4 | 2.92 Billion CNY | 46.88% |
| 2022 FY | 1.81 Billion CNY | 29.3% |
| 2022 Q4 | 1.81 Billion CNY | 13.05% |
| 2022 Q3 | 1.6 Billion CNY | 4.37% |
| 2022 Q2 | 1.53 Billion CNY | 6.7% |
| 2022 Q1 | 1.44 Billion CNY | 2.7% |
| 2021 Q2 | 1.23 Billion CNY | -5.62% |
| 2021 Q1 | 1.3 Billion CNY | 3.73% |
| 2021 FY | 1.4 Billion CNY | 11.61% |
| 2021 Q3 | 1.32 Billion CNY | 7.16% |
| 2021 Q4 | 1.4 Billion CNY | 6.39% |
| 2020 Q4 | 1.25 Billion CNY | 14.9% |
| 2020 Q1 | 767.37 Million CNY | 5.0% |
| 2020 FY | 1.25 Billion CNY | 72.25% |
| 2020 Q2 | 1.2 Billion CNY | 57.58% |
| 2020 Q3 | 1.09 Billion CNY | -9.4% |
| 2019 Q4 | 730.8 Million CNY | 0.0% |
| 2019 Q2 | 644.51 Million CNY | 0.0% |
| 2019 FY | 730.8 Million CNY | 26.72% |
| 2019 Q1 | - CNY | -100.0% |
| 2018 Q2 | 546.26 Million CNY | 8.09% |
| 2018 Q4 | 576.7 Million CNY | 0.0% |
| 2018 FY | 576.7 Million CNY | 1.99% |
| 2018 Q1 | 505.39 Million CNY | -10.62% |
| 2017 FY | 565.42 Million CNY | 9.15% |
| 2017 Q4 | 565.42 Million CNY | 0.0% |
| 2017 Q1 | - CNY | -100.0% |
| 2017 Q3 | 565.42 Million CNY | 0.0% |
| 2016 Q1 | 593.5 Million CNY | 96.09% |
| 2016 Q3 | 518.02 Million CNY | -12.72% |
| 2016 FY | 518.02 Million CNY | 71.15% |
| 2016 Q2 | 593.5 Million CNY | 0.0% |
| 2016 Q4 | 518.02 Million CNY | 0.0% |
| 2015 Q2 | 318.62 Million CNY | 0.0% |
| 2015 Q4 | 302.66 Million CNY | 0.0% |
| 2015 Q3 | 302.66 Million CNY | -5.01% |
| 2015 FY | 302.66 Million CNY | 21.76% |
| 2015 Q1 | 318.62 Million CNY | 28.17% |
| 2014 Q3 | 248.58 Million CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 Q4 | 248.58 Million CNY | 0.0% |
| 2014 FY | 248.58 Million CNY | 24.53% |
| 2013 FY | 199.61 Million CNY | 0.0% |